Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Peroxisome proliferator-activated receptor gamma (PPAR-gamma) |
Target Info
|
Agonist |
[2] |
| References |
Top |
| REF 1 |
ClinicalTrials.gov (NCT00353587) Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin. U.S. National Institutes of Health.
|
| REF 2 |
MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema. Mol Endocrinol. 2009 Jul;23(7):975-88.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
